Home6919 • TPE
add
Caliway Biopharmaceuticals Co Ltd
Previous close
$942.00
Day range
$904.00 - $994.00
Year range
$436.00 - $994.00
Market cap
141.79B TWD
Avg Volume
1.69M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
| (TWD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 9.36M | -37.19% |
Operating expense | 135.35M | 10.35% |
Net income | -56.14M | 52.55% |
Net profit margin | -599.57 | 24.46% |
Earnings per share | -0.30 | — |
EBITDA | -114.92M | -16.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.67B | 160.51% |
Total assets | 9.77B | 155.34% |
Total liabilities | 73.70M | -13.86% |
Total equity | 9.70B | — |
Shares outstanding | 153.48M | — |
Price to book | 14.91 | — |
Return on assets | -3.28% | — |
Return on capital | -3.30% | — |
Cash Flow
Net change in cash
| (TWD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -56.14M | 52.55% |
Cash from operations | -42.00M | 65.87% |
Cash from investing | -2.10B | -2,797.15% |
Cash from financing | 18.12M | -99.40% |
Net change in cash | -2.13B | -170.96% |
Free cash flow | -129.85M | — |
About
Founded
2012
Website
